emricasan (IDN 6556) / Amerimmune |
| Terminated | 2 | 23 | US, Europe | IDN-6556, emricasan, PF-03491390, Placebo | Conatus Pharmaceuticals Inc. | Acute on Chronic Hepatic Failure, Acute Liver Failure, Liver Cirrhosis, Acute Alcoholic Hepatitis | 01/15 | 02/15 | | |
NCT02230683: A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension |
|
|
| Completed | 2 | 23 | US | IDN-6556, emricasan, PF-013491390 | Conatus Pharmaceuticals Inc. | Liver Cirrhosis, Hepatic Cirrhosis, Portal Hypertension | 05/15 | 06/15 | | |
NCT02230670: A Study of IDN-6556 in Subjects With Liver Cirrhosis |
|
|
| Completed | 2 | 87 | US | IDN-6556, emricasan, PF-03491390, Placebo | Conatus Pharmaceuticals Inc. | Liver Cirrhosis, Hepatic Cirrhosis | 01/16 | 01/16 | | |